Bioactive natural secondary metabolites for targeted therapeutic discovery

Overview

This offering comprises a collection of bioactive natural secondary metabolites derived from olive, tobacco, marine, and microbial sources. These compounds feature unique regioselectivity and chemical scaffolds that are uncommon in synthetic chemistry, making them valuable starting points for drug discovery. Many originate as chemical defense agents in nature, which supports their potential for diverse and potent bioactivities against validated therapeutic targets.

The collection includes oleocanthal from olive phenolics targeting c-MET and SMYD2 pathways, tobacco cembrenediols (4R targeting IDO1/TDO2 and 4S targeting VEGFR2) and related analogs, marine cembranoids including sarcophine (EZH2 inhibitor), latrunculin A, penitrem A, and others, as well as the microbial metabolite pseurotin A. These targets represent well-validated pathways in oncology and related disease areas.

Technical specifications

Compound classes and sources:

• Olive phenolics, including oleocanthal with activity against c-MET and SMYD2
• Tobacco cembrenediols in 4R and 4S configurations, plus structural analogs, targeting IDO1/TDO2 and VEGFR2 respectively
• Marine cembranoids, including sarcophine as an EZH2 inhibitor, latrunculin A, and penitrem A
• Microbial metabolites, including pseurotin A

Key features:

• Naturally derived scaffolds with regioselectivity difficult to achieve through synthetic routes
• Bioactivity demonstrated against multiple validated disease targets across oncology-related pathways
• Compounds sourced from diverse origins (plant, marine, microbial), broadening structural diversity
• Potential for use as lead compounds, biochemical probes, or starting points for medicinal chemistry optimization

Technology readiness level

These compounds are positioned for early-stage collaborative research and drug discovery partnerships. The library represents an opportunity for joint exploration of structure-activity relationships, target validation, and lead optimization against the indicated molecular targets.